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The need for sensitive, robust, portable, and inexpensive biosensing platforms is of significant interest in clinical
applications for disease diagnosis and treatment monitoring at the point-of-care (POC) settings. Rapid, accurate
POC diagnostic assays play a crucial role in developing countries, where there are limited laboratory
infrastructure, trained personnel, and financial support. However, current diagnostic assays commonly require
long assay time, sophisticated infrastructure and expensive reagents that are not compatible with
resource-constrained settings. Although paper and flexible material-based platform technologies provide
alternative approaches to develop POC diagnostic assays for broad applications in medicine, they have technical
challenges integrating to different detection modalities. Here, we address the limited capability of current paper
and flexible material-based platforms by integrating cellulose paper and flexible polyester films as diagnostic
biosensing materials with various detection modalities through the development and validation of new widely
applicable electrical and optical sensing mechanisms using antibodies and peptides. By incorporating these
different detection modalities, we present selective and accurate capture and detection of multiple biotargets
including viruses (Human Immunodeficieny Virus-1), bacteria (Escherichia coli and Staphylococcus aureus),
and cells (CD41 T lymphocytes) from fingerprick volume equivalent of multiple biological specimens such as
whole blood, plasma, and peritoneal dialysis effluent with clinically relevant detection and sensitivity.
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R

apid diagnosis has broad applications in multiple disciplines including clinical medicine, immunoassays,
food safety, environmental monitoring, and veterinary medicine1–5. Among these applications, development of easy-to-use, rapid, and inexpensive point-of-care (POC) diagnostic assays, particularly in resourceconstrained settings, remains an urgent need. POC diagnostics facilitate timely opportunities for detection and
control of disease, treatment monitoring and counseling in both developed and developing countries to solve real
world healthcare problems6,7. Paper and flexible material-based platform technologies have created an exciting
avenue in the area of POC diagnostics. These technologies have also potential to shift the paradigm in developing
diagnostic assays, particularly for the developing world, as they are thin, light, flexible, inexpensive, and materials
are readily available around the world. These platforms are easy-to-fabricate, mass-producible, easy-to-use, and
disposable1,8. Paper-based platforms can also absorb fluid samples through capillary effect, and be incinerated for
convenient and safe disposal8. Therefore, these platforms provide attractive strategies for developing affordable
tools with broad applications such as drug development, water and environment quality monitoring, and
infectious diseases diagnosis in resource-constrained settings8,9. Current paper and flexible material-based platforms utilizing colorimetric10, fluorometric11, and electrochemical approaches12 require complex labeling steps to
amplify the signal. Further, these platforms need expensive infrastructure and skilled personnel for their fabrication and operation, which are significant challenges for their deployment into the POC settings. Although
there has been a considerable number of studies on paper and flexible material-based biosensors, there is a need
for studies demonstrating (i) their applicability to different detection modalities such as electrical and optical
sensing, and (ii) their detection capability for various biotargets from a variety of clinical sample types including
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whole blood, serum, saline, dialysis effluent or lysates with high
sensitivity and specificity. By employing three different paper and
flexible material-based platforms incorporated with electrical and
optical sensing modalities, we address these major challenges with
specific examples for their broad use as diagnostic device materials.
In this manuscript, we demonstrate different paper and flexible
material-based diagnostic platforms with biosensing applications to
detect various bioagents in whole blood, serum and peritoneal fluid.
These distinct platforms have been integrated with sensing modalities including impedance spectroscopy of biotargets, nanoparticle
aggregation using a mobile phone-based detection system, and lensless shadow imaging technology that do not require any signal amplification. As clinical disease models, we present applications of paper
and flexible material-based platforms focusing on (i) detection of
Human Immunodeficiency Virus-1 (HIV-1) by capturing and
detecting multiple HIV-1 subtypes, (ii) CD41 T lymphocytes, and
(iii) detection of bacterial infections such as Escherichia coli (E. coli)
and Staphylococcus aureus (S. aureus) in various clinical matrices
with high sensitivity and specificity. Thus, we demonstrate that paper
and flexible material-based platforms can be widely applied to a
variety of settings including medical diagnostic and biology laboratories. The combination of these sensing mechanisms on paper and
flexible materials offers a promising opportunity to create diagnostic
assays that meet the requirements of POC disease detection and
treatment monitoring.

Results
HIV detection on a flexible polyester film-based electrical sensing
platform. A flexible polyester film with two rail silver electrodes in
microfluidic channels was employed as an electrical sensing platform
to detect viruses (HIV-1) through viral lysate impedance spectroscopy (Figs. 1A, S1, and S2). Here, biological samples spiked with
HIV-1 were used as a clinical disease model for HIV-1 diagnosis.
HIV-1 spiked in samples were first captured and isolated off-chip
using magnetic beads conjugated with biotinylated polyclonal antigp120 antibodies. To detect captured HIV-1, we evaluated the
impedance magnitude and phase spectra of viral lysate samples for
multiple HIV-1 subtypes including A, B, C, D, E, G, and panel over a
range of frequencies between 100 Hz and 1 MHz (Figs. 2A and 2B).
Our preliminary experiments were performed using HIV-spiked into
Dulbecco’s phosphate buffered saline (DPBS) samples. Captured
viruses were then detected through viral lysate impedance spectroscopy on the platform. Viral lysis step increases the electrical
conductivity and decreases the bulk impedance magnitude of the
solution. An equivalent electronic circuit model was developed to
calculate the impedance magnitude of the viral lysate samples (Fig.
S3) as earlier developed13. The average impedance magnitude spectra
of the viral lysate samples for all HIV-1 subtypes were below the
average impedance magnitude spectrum of the control samples for
frequencies between 100 Hz and 100 kHz (Fig. 2A). Control samples
were prepared by mixing HIV-free DPBS and conjugated magnetic
beads. The impedance magnitude of the viral lysate samples for
frequencies above 100 kHz was same as the impedance magnitude
of the control samples (Fig. 2A). We observed that the maximum
impedance magnitude shift for all HIV-1 subtypes with respect to
control samples occurred at 1,000 Hz (Fig. 2A). Therefore, we chose
this frequency to further statistically compare the impedance magnitude results. Fig. 2C shows the impedance magnitude of the viral
lysate samples as well as control sample at 1,000 Hz. The impedance magnitude of the viral lysate samples was significantly lower
than the impedance magnitude of the control samples (n 5 3, p ,
0.05), indicating that the captured and lysed viruses changed the
electrical conductivity of the solution, thus can be detected using
impedance spectroscopy (Fig. 2C). We also observed no significant
difference between the impedance magnitudes of multiple HIV-1
subtypes (Figs. 2C and 2D, n 5 3, p . 0.05), which indicated that
SCIENTIFIC REPORTS | 5 : 8719 | DOI: 10.1038/srep08719

this method of virus sensing was able to detect multiple HIV
subtypes. The impedance magnitude of the viral lysate samples
were also normalized with respect to the impedance magnitude of
control samples at 1,000 Hz as shown in Fig. 2D. These results
showed an impedance magnitude change of 20% to 30% compared
with the control samples. The repeatability of the impedance
magnitude measurements was observed to be between 88% and
99% (Fig. 2E and Supplementary Information). We evaluated the
virus capture on magnetic beads conjugated with antibodies using
green fluorescent protein (GFP)-tagged HIV-1 (Fig. S4). We also
investigated the effect of time on the impedance magnitude of the
viral lysate samples, and we did not observe a significant difference in
the impedance magnitude of the samples during the time of
performing experiments (n 5 3, p . 0.05) (Fig. S5).
To evaluate the specificity of this platform for HIV-1 detection, we
used Epstein-Barr virus (EBV). The impedance magnitude spectra of
HIV-1, EBV, and the mixture of HIV-1 and EBV samples were
measured and compared with control samples (Fig. 3A). Controls
were virus-free DPBS samples. The impedance magnitude spectra of
the HIV-1 and the mixture samples were lower compared to control
and EBV samples (Fig. 3A). Further, the mean impedance magnitude
spectrum of EBV samples was not significantly lower than control
samples (Fig. 3A). The impedance magnitude of the samples was
then analyzed at 1,000 Hz. The impedance magnitude of HIV-1
and the mixture of HIV-1 and EBV samples were significantly different compared to control samples at 1,000 Hz (Fig. 3B, n 5 3, p ,
0.05). The impedance magnitude of HIV-1 samples was not statistically different than the mixture of HIV-1 and EBV at 1,000 Hz
(Fig. 3B, n 5 3, p . 0.05). We also observed that the repeatability
of these impedance magnitude measurements were between 79% and
99% (Fig. 3C).
To further evaluate the sensing ability of the platforms in complex
biological samples, HIV samples were selectively isolated and
detected from whole blood and plasma. Spiked viruses into whole
blood and plasma samples were captured and isolated using biotinylated polyclonal anti-gp120 antibodies, washed 4 times with 20%
glycerol solution, and lysed for impedance spectroscopy detection
(Fig. S6). The impedance magnitude spectra of the viral lysate samples are shown in Figs. S6A and S6B. The impedance magnitude of
viral lysate samples were significantly lower compared to the impedance magnitude of control samples (whole blood and plasma without
viruses) at 1,000 Hz and 1 V (Figs. 3D and 3E, n 5 3, p , 0.05). The
impedance magnitude shift in whole blood and plasma samples was
found to be 13 6 2% and 16 6 5%, respectively (Fig. 3F). No significant difference was observed between the impedance magnitude
shift in whole blood and plasma samples, indicating that the viruses
were detected both in plasma and whole blood (Fig. 3F, n 5 3, p .
0.05). Further, using higher sample volumes up to 5 mL increased
the sensitivity of the platform, where the impedance magnitude of
the viral lysate samples was significantly lower than control samples
(virus-free DPBS samples) (Fig. S7, n 5 3, p , 0.05). We were able to
detect viruses using this polyester film-based electrical sensing platform in HIV-spiked DPBS samples with viral loads on the order of
106 copies/mL (Fig. S7).
Electrical sensing is a powerful modality to develop portable, rapid,
and sensitive diagnostic tools2,3,13–15. By employing polyester film as a
flexible material, this label-free platform can potentially be used for the
capture and detection of multiple pathogens with well-known biomarkers using impedance spectroscopy of their lysate. Here, we particularly present the ability of this platform to detect HIV-1 at the viral
concentrations matching acute HIV-1 infection stage, where there is
maximum virus reproduction (106–108 copies/mL) and minimum
antibody concentration16. HIV-infected individuals can transmit the
infection substantially during acute stage of HIV infection17. Thus,
acute HIV-1 detection is crucial, where current rapid tests such as
OraQuick or Determine HIV-1/2 Ag/Ab Combo rapid test cannot
2
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Figure 1 | Schematic of seamlessly integrated paper and flexible substrate-based platforms with broadly applicable electrical and optical sensing
modalities. (A) Flexible electrodes on polyester film-based electrical sensing platform for HIV detection. (i) Viruses are captured using streptavidin-coated
magnetic beads conjugated with biotinylated polyclonal anti-gp120 antibodies in clinically relevant samples such as whole blood (ii) Sample is washed to remove
electrically conductive solution. (iii) Captured viruses are lysed using 1% Triton X-100, releasing to release ions and biomolecules of the captured viruses. These
biomolecules change the electrical conductivity of the solution. (iv) The impedance magnitude of the viral lysate samples decreases compared with that of
control samples. Figure 1A is drawn by H.S. (B) Nanoparticle aggregation concept for bacteria detection on a cellulose paper and its incorporation with mobile
phone camera. (i) Gold nanoparticles (AuNPs) are modified with 11-Mercaptoundeconoic acid (MUA), N-Ethyl-N’-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC), and N-hydroxysuccinimide (NHS) to form coupling groups on nanoparticle surface. AuNPs are further functionalized with specific
recognition elements for bacteria pathogens. (ii) Bacteria-spiked samples are added to the modified nanoparticle solution. Bacteria samples cause nanoparticle
aggregation and change the color of solution as detected with a mobile phone. Figure 1B is drawn by F.I. (C) Lensless imaging detection and counting of CD41 T
lymphocytes on polyester film-based platform with microchannels. (i) Surface chemistry on the platform are designed to immobilize biotinylated anti-CD4
antibodies using NeutrAvidin on chemically activated surface including N-g-Maleimidobutyryloxy succinimide ester (GMBS) and 3-Mercaptopropyl
trimethoxysilane (3-MPS) modifications. (ii) CD41 T lymphocytes are selectively captured from a whole blood sample on the surface of platform. (iii) Noncaptured cells are washed away from the microchannels of platform. (iv) Captured CD41 T cells are then detected and quantified using a lensless shadow
imaging technology. (v) Shadows of captured CD41 T cells on the substrate. Figure 1C is drawn and designed by H.S., W.A. and M.H.Z.
SCIENTIFIC REPORTS | 5 : 8719 | DOI: 10.1038/srep08719
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Figure 2 | Impedance spectroscopy results for HIV-spiked DPBS samples. Impedance magnitude (I.M.) (A) and phase spectra (B) of lysed HIV-1
subtypes A, B, C, D, E, G, and panel for frequencies between 100 Hz and 1 MHz measured on the flexible polyester film-based electrical sensing devices.
(C) Impedance magnitude of HIV-1 lysate samples (HIV subtypes A, B, C, D, E, G, and panel) at 1,000 Hz and 1 V, where there was maximum impedance
magnitude shift. (D) Normalized impedance magnitude change of HIV-1 lysate samples with respect to control samples. (E) Repeatability of the
measured impedance magnitude for HIV subtypes A, B, C, D, E, G, and panel. The system demonstrated a repeatability between 88% and 99%. The
control samples were virus-free DPBS samples. Statistical assessment on the results was performed using ANOVA with Tukey’s posthoc test for multiple
comparisons. Statistical significance threshold was set at 0.05 (p , 0.05). Error bars represent standard deviation of the mean (n 5 3). Asterisk indicates
statistically significant impedance magnitude change compared to all other groups. The viral loads of these HIV-1 subtypes were 1.74 3 108, 1.2 3 108,
1.17 3 108, 2.9 3 108, 8.39 3 108, 6.53 3 108, and 1.49 3 109 copies/mL for HIV subtypes A, B, C, D, E, G, and panel, respectively.

detect HIV infection due to low concentration of antibodies before the
seroconversion, and poor sensitivity to detect acute HIV in field studies16,18,19. These statistics clearly highlight the urgent and unmet clinical
need for a POC viral load test for acute HIV detection20. Here, we have
developed an inexpensive (less than $2 in material cost) (Table S1),
and disposable electrical sensing platform on a flexible material (i.e.,
polyester film) to selectively capture and detect viruses (HIV-1) in
clinical samples such as whole blood and plasma. However, this platform requires off-chip sample preparation including virus capture
using antibodies, washing, and virus lysis. By employing further developments in sample processing steps, this platform technology can be
potentially automated for POC applications.
Bacteria detection and quantification on a cellulose paper-based
nanoparticle aggregation substrate and image acquisition with a
mobile phone. An ultra-sensitive biosensing platform was developed
to detect pathogens through nanoparticle aggregation on a cellulose
paper (Fig. 1B). The nanoparticle aggregation strategy was adapted as
a sensing mechanism for detection of E. coli and S. aureus as model
bacterial pathogens. In this platform, gold nanoparticles were first
modified with specific recognition elements to capture pathogens in
the solution. We subsequently transferred the modified nanoparticle
solution to a disposable paper that allowed distribution of aggregated
nanoparticles by utilizing capillary effect on its native structure. thus
obtaining uniform distribution for quantitative analysis. To evaluate
the chemical modifications on nanoparticle surface, 11Mercaptoundeconoic acid (MUA), N-Ethyl-N’-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide
(NHS) coupling agents, and Lipopolysaccharide Binding Protein
(LBP) for recognition of E. coli were used to modify gold
nanoparticles. The maximum extinction wavelength peaks of
nanoparticle colloids resulted in red-shifts after each surface
modification (Fig. S8A). The conjugated nanoparticles were mixed
SCIENTIFIC REPORTS | 5 : 8719 | DOI: 10.1038/srep08719

with E. coli-spiked solutions, and the nanoparticles then aggregated
due to E. coli-nanoparticle interactions (Figs. S8B and S9).
Collectively, the results in Fig. S8 demonstrated that the final
morphology, structure, and status of the nanoparticle aggregation
was acutely triggered by the presence of E. coli in the solution, which
caused a visible change in the color from red to blue.
To this end, the platform was validated by spiking E. coli into three
distinct media: DPBS, whole blood serum, and peritoneal dialysis
(PD) fluid (Fig. 4). These three media without E. coli were used as
controls. The blue color was obtained in E. coli-spiked samples, and it
was also distinguished from control samples (red color) (Fig. 4A).
This color change in nanoparticles is associated with the interference
of biomolecular interactions between the intermolecular interactions. Control experiments (E. coli-free samples in DPBS, whole
blood serum, and PD fluid) resulted in red-colored colloids of nanoparticles since there is no recognition site for LBP protein in the
solution. Therefore, these experiments showed that blue color formation was not due to non-specific interactions, and it was observed in
the presence of target bacteria (E. coli). For quantitative analysis, the
solution containing modified nanoparticles and bacteria was also
sampled and dried on a paper within 10 minutes, and a mobile
phone camera (Sony Ericson i790) was then employed as an image
acquisition step for nanoparticle aggregate spots (Fig. 1B). Further,
the ability to detect E. coli with a naked eye was confirmed by measuring the intensity with a customized imaging analysis tool on the
computer, which provided color intensities of images using a customized MATLAB code in terms of red (R), green (G), and blue (B)
pixel values as previously presented21. Briefly, the code was used (i) to
obtain RGB pixel values and (ii) to calculate color intensity for each
image. In these experiments, R value allowed a broader color intensity range, and thus, we continued to employ R values for measurements. The area of interest was manually selected in the middle of
nanoparticle aggregate spots with ,0.25 cm2 on the cellulose paper
4
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Figure 3 | Evaluation of specificity characteristics for the flexible material (i.e., polyester film)-based electrical sensing platform. EBV- and HIV-spiked
DPBS samples were used in the experiments. Control samples were virus-free DPBS. Average impedance magnitude (A) for lysed HIV-1 subtype A, EBV,
and mixture of HIV subtype A and EBV for frequencies between 100 Hz and 1 MHz. (B) Impedance magnitude of the lysed HIV-1 subtype A, EBV, and
mixture of HIV subtype A and EBV samples at 1,000 Hz and 1 V. (C) Repeatability of the impedance magnitude shift for HIV-1 subtype A, EBV, and
mixture of HIV and EBV samples. The system demonstrated repeatability between 79% and 99%. Average impedance magnitude of control and lysed
HIV-1 subtype C spiked in whole blood (D) and plasma (E) at 1,000 Hz and 1 V. The control samples were virus-free blood and virus-free plasma for
experimental results reported in (D) and (E), respectively. Error bars represent standard error of the mean (n 5 3). (F) Normalized impedance magnitude
change of HIV-1 lysate samples with respect to control samples at 1,000 Hz and 1 V in spiked whole blood and plasma samples. Statistical assessment on
the results was performed using ANOVA with Tukey’s posthoc test for multiple comparisons. Statistical significance threshold was set at 0.05 (p , 0.05).
Error bars represent standard error of the mean (n 5 3). Brackets connecting individual groups indicate statistically significant impedance magnitude
difference (p , 0.05). The viral loads of the HIV-1 subtype A and C used here were 1.74 3 108, 1.17 3 108 copies/mL, respectively.

surface. Further, as we demonstrated previously21,22, this code can
also be adapted to a mobile phone application for automatic region
selection (given a specific region is marked on the paper) and
analysis.
To evaluate the limit of detection, control and E. coli samples were
analyzed using statistical methods, and the lowest detectable concentration was observed to be 8 colony forming units (CFUs)/mL for all
samples (Fig. 4B–D). These results demonstrated the employment of
the nanoparticle aggregation approach-operated on a cellulose paper
for the detection and identification of pathogens at low concentrations. For multiplexing and specificity experiments, we designed
three sets of experiments: (i) the sampling of S. aureus (105 CFUs/
mL) into anti-LTA antibody-modified gold nanoparticle solution,
(ii) the sampling of E. coli (105 CFUs/mL) into anti-LTA antibodymodified gold nanoparticle solution, and (iii) the sampling of mixed
bacteria (S. aureus (105 CFUs/mL) and E. coli (105 CFUs/mL)) into
anti-LTA antibody-modified gold nanoparticle solution (Fig. 4E).
From multiplexing perspective, S. aureus-spiked samples presented
statistically different results than that of E. coli-spiked samples (n 5
5, p , 0.05) (Fig. 4E). Further, we observed a minimal cross-reactivity (non-specific binding) against E. coli that is statistically smaller
than the data in mixture samples (n 5 5, p , 0.05) (Fig. 4E). At the
third set of experiments, we evaluated the specificity performance of
the platform with mixed samples. Statistical analysis demonstrated
that there was no significant difference between the results obtained
SCIENTIFIC REPORTS | 5 : 8719 | DOI: 10.1038/srep08719

from S. aureus and mixture samples (n 5 5, p . 0.05) (Fig. 4E). Since
there is no notable interaction between anti-LTA antibody-modified
gold nanoparticles and E. coli, the color intensity originated due to S.
aureus confirmed selective capture and detection of S. aureus from
the mixed samples (Fig. 4E). In addition, to assess the MATLAB code
performance for analysis, S. aureus experiments were further evaluated with other mobile phones such as iPhone 4, Samsung i9300
Galaxy S3 and HTC Vivid, which have different cameras for the
image acquisition (Fig. 4F). Without any modification on the code,
we did not observe any statistical difference between the results
obtained from various mobile phone cameras (n 5 5, p . 0.05).
Overall, we demonstrated a specific and multiplexed platform for
the detection of different bacterial pathogens using an unconventional nanoparticle aggregation approach incorporated with cellulose paper.
From a diagnostics perspective, colorimetric ELISA-based detection assays are currently employed as a conventional laboratory
method, where the corresponding detection signal is formed by the
conversion of enzyme substrate into a colored product, and the signal
intensity is measured using a spectroscopic plate reader21. Although
the color changes can be distinguished by a naked eye, these assays
require multiple operational steps and expensive infrastructure. In
our assay, the formation of colored solutions is employed to quantitatively detect target pathogens such as E. coli and S. aureus. In this
platform, the nanoparticle aggregation is associated with the repuls5
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Figure 4 | Cellulose paper-based nanoparticle aggregation for the detection of bacteria with a mobile phone system. Bacteria-spiked samples were first
added into the modified gold nanoparticle solution, and then, transferred to a cellulose paper for distribution of nanoparticles due to capillary effect. (A)
The images of sample spots were taken using a mobile phone camera for image acquisition, and analyzed using an image processing MATLAB code in the
computer. Red (R) pixel intensity value was used in the data analysis. (B) E. coli-spiked into DPBS samples ranging from 8 to 1.5 3 106 CFUs/mL were
evaluated. The limit of detection (LOD) was observed to be 8 CFUs/mL (n 5 5). (C) E. coli-spiked into serum samples ranging from 8 to 1.5 3 106 CFUs/
mL were evaluated. The LOD was observed as 8 CFUs/mL (n 5 5). (D) E. coli-spiked in PD fluid samples ranging from 8 to 1.5 3 106 CFUs/mL were
evaluated. The LOD was observed as 8 CFUs/mL (n 5 5). E. coli-free solutions were used as control samples, and the corresponding signals were
represented in line and dashes in the plots to show the mean and standard error of mean, respectively (n 5 5). (E) Three sets of experiments were designed
for multiplexing and specificity experiments. S. aureus (105 CFUs/mL) were applied into anti-LTA antibody-modified gold nanoparticle solution for
multiplexing. E. coli (105 CFUs/mL) were sampled into anti-LTA antibody-modified gold nanoparticle solution for specificity. A mixed bacteria solution
was examined with anti-LTA antibody-modified gold nanoparticle solution for nonspecific interactions. Statistical analysis demonstrated that S. aureus
and mixture experiments were statistically different than E. coli samples (n 5 5, p , 0.05), and there was no significant difference observed between S.
aureus and mixture samples (n 5 5, p . 0.05). (F) Evaluation of image code with other mobile phone cameras. S. aureus experiments were further assessed
with iPhone 4, Samsung i9300 Galaxy S3 and HTC Vivid. There was no statistical difference between various mobile phone cameras (n 5 5, p . 0.05).
Statistical analysis was described in Supplementary Information. Brackets connecting individual groups indicate statistically significant difference. Error
bars represent standard error of the mean.

ive electrostatic forces between nanoparticles, and resulted in a blue
color in the presence of the pathogens (Fig. 1B)23,24. Therefore, the
solution absorbs the light at longer wavelengths compared to nonaggregated form25. The blue and red colors are simply distinguished
at a glance; thus, the presence of pathogens are detected with the
naked eye, and it is further quantitatively analyzed using an image
analysis tool coupled with image acquisition from a mobile phone.
Thus, the current platform offers a simpler and inexpensive alternative to traditional detection methods. However, labeling with antibodies and peptides are still needed for the detection of biotargets. By
SCIENTIFIC REPORTS | 5 : 8719 | DOI: 10.1038/srep08719

employing new binders including carbohydrates and other biological
recognition elements, this detection strategy will potentially be tailored
to other POC applications in the resource-constrained settings.
From bacterial infection perspective, E. coli and S. aureus are the
most common bacterial pathogens that pose significant clinical
threats including food poisoning, skin infections and sepsis at low
concentrations (10–1,000 CFUs/mL)26–28. Further, E. coli is reported
as one of the most common species for bacterial infection observed in
PD patients29,30. Here, E. coli spiked in PD samples were used as a
clinical disease model. In end-stage renal disease (ESRD) patients,
6

www.nature.com/scientificreports
kidney replacement or dialysis to preserve any residual renal function is required. It is estimated that more than half a million patients
will require dialysis in 2020 with the rising disease prevalence in the
US31. However, a barrier in the clinical practice for broad adaption
for PD has been the risk of peritonitis, i.e., inflammation of the
peritoneum. Peritonitis has to be detected early and treated before
it becomes a chronic case. Detecting bacterial infection offers a great
promise for the early diagnosis of peritonitis as well as other bacteriainduced diseases such as sepsis26 and ventilator-associated pneumonia32 at the bedside and resource-constrained settings, where time
consuming and expensive assays such as cell cultures, ELISA, and
nucleic acid-based tests may not be available.
CD41 T lymphocyte capture and detection on a flexible polyester
film-based imaging platform. A flexible polyester film with
microfluidic channels was employed to selectively and efficiently
capture and quantify cells of interest in unprocessed whole blood
samples. Here, we evaluated this platform to capture and quantify
CD41 T lymphocytes in fingerprick whole blood samples for POC
HIV diagnosis as a clinical disease model (Fig. 1C). We have
evaluated ten different flexible substrates to fabricate microfluidic
devices for capturing and counting CD41 T cells from whole
blood. We also evaluated these substrates for optical compatibility
with wide-field of view lensless imaging on a complementary
metal-oxide-semiconductor (CMOS) sensor. These flexible
substrates are polyester-based transparency films that are routinely
used for printing and lamination. All substrates were first imaged
using bright-field (BF) microscopy to visualize any inbuilt debris
(Fig. S10). Some of these substrates such as 3M, 7333 HostaphanH,
2262N HostaphanH, 2261N HostaphanH, and Grafix showed debris
and small inbuilt particles that could hinder detection of captured
cells. As captured CD41 T cells were stained with fluorescent dyes, we
first evaluated these substrates for autofluorescence at various
wavelengths (blue, green, and red regions) using a fluorescent
microscope (Fig. S10). The substrates having large number of
inbuilt debris particles also showed higher autofluorescence when
samples were imaged using a fluorescent microscope (Fig. S10). To
quantify the autofluorescence intensity of these images, we calculated
the mean autofluorescence intensity of substrates using NIH ImageJ
software (http://rsb.info.nih.gov/nih-image/). The intensity
histograms, corresponding microscope images, and the mean
intensity plots were demonstrated in Figures S10 and S11. Here,
we used a glass slide as a standard substrate for this
characterization. The substrate that showed comparable
autofluorescence characteristics with glass substrates was chosen
for the device assembly, and thus, 3915 300ga HostaphanH
material was used for further studies (Fig. 5A). Although 3915
HostaphanH material resulted in higher autofluorescence at DAPI
excitation, this autofluorescence was not high enough to block the
strong DAPI signal. Comparing the substrate autofluorescence in
green (GFP) and red (CY5) excitation, we observed that 3915
HostaphanH material showed lesser autofluorescence in red
excitation. The autofluorescence difference between glass and 3915
HostaphanH material at red excitation was also less as compared to
green excitation (Fig. 5A).
For the capture of CD41 T cells, this flexible platform was
assembled and functionalized to immobilize the capture antibody
(Fig. 1C). To optimize the surface chemistry, we have used various
concentrations of NeutrAvidin-conjugated-FITC (NA-FITC) after
N-gamma-Maleimidobutyryl-oxysuccinimide ester (GMBS) functionalization step ranging from 0.1 mg/mL to 1 mg/mL. We
observed an increase in fluorescent intensity up to 0.5 mg/mL NAFITC concentration. We then selected 0.5 mg/mL NA-FITC concentration for further experiments as the fluorescent intensity saturated
beyond this concentration (Fig. 5B). The assembled devices were
further functionalized with various concentrations of anti-CD4 capSCIENTIFIC REPORTS | 5 : 8719 | DOI: 10.1038/srep08719

ture antibody (5, 10, and 20 mg/mL). A drop of whole blood (10 mL)
was sampled into the inlet of microfluidic channels of the platform.
The blood filled the whole channel due to capillary forces, without
using a micro-pump (Movie S1). The flexible film-based devices were
bent up and down to mix the blood inside the channels to enhance
cell surface interactions to improve cell capture (Movie S2). DAPI
staining was used to stain nucleated white blood cells (WBCs),
whereas Alexa Flour 647 (AF647) anti-CD4 antibody was used to
stain captured CD41 T cells. The surfaces were imaged using a fluorescent microscope and cell capture efficiency and specificity were
calculated (Supplementary Information). The bright-field and fluorescent images of the captured cells are shown in Fig. 5C. Captured
WBCs and CD41 T cells can be observed clearly through the flexible
substrate. The CD41 T cell capture efficiencies were 51.8% 6 13.5%,
64.0% 6 10.1%, and 66.7% 6 10.7% for devices functionalized with
5, 10, and 20 mg/mL capture antibody, respectively (Fig. 5D). The
CD41 T cell capture specificities were 85.2% 6 5.0%, 75.7% 6 4.8%,
and 76.0% 6 5.1% for devices functionalized with 5, 10, and 20 mg/mL
capture antibody, respectively (Fig. 5E). We observed that increasing
the capture antibody concentration increased the CD41 T cell capture efficiency and reduced the capture specificity. Here, this flexible
material (i.e., polyester film)-based platform can be integrated with
CMOS lensless imaging platform for rapid detection of CD41 T cells
(Fig. S12A). Shadows of the captured cells are imaged by lensless
sensor in a few seconds (Figs. 1C (iv) and S12B–C). The CMOS
sensor allowed rapid cell detection without using a fluorescent tag.
However, transparency films/substrates with higher clarity and quality would enhance captured cell shadow contrast for quantification.
Overall, the developed platform allows efficient CD41 T cell counting using fingerprick volume of unprocessed whole blood samples at
the POC. These results indicate that the platform has the potential to
replace conventional non-disposable glass-based rigid biosensing
devices in the future given that the capture efficiency and specificity
are further increased beyond 90% by further optimization of the
materials and optical properties of the films as a substrate. In the
current form, the device processing requires manual pipetting steps
for blood injection and channel washing, but the developed platform
can potentially be made fully automated by integrating microfluidic
devices to disposable cartridges.
From HIV diagnostic perspective, accurate CD41 T cell count is
essential for HIV-1 diagnosis and treatment monitoring33–35. Current
World Health Organization (WHO) guidelines recommend antiretroviral therapy (ART) for individuals with CD41 T cell count of less
than 500 cells/ml36. Conventional CD41 T cell counting methods
require flow cytometer, i.e., a gold standard method, for CD41 T
cell counting in the developed world. This method, however, requires
a skilled operator, expensive infrastructure and reagents. The disposable and flexible biosensing platform for efficient counting of CD41
T cells has potential to address some of these global health challenges
at the POC settings.

Conclusion
Paper and flexible material-based biosensing platforms are powerful
tools to create affordable and disposable POC disease detection and
treatment monitoring assays, particularly for the resource-constrained settings. There is a need for their integration with different
detection strategies for distinct biotargets from multiple biological
and clinical matrices such as whole blood, serum, saline buffer, dialysis effluent or lysates with high sensitivity and specificity. In this
manuscript, as clinical models, we demonstrated the isolation and
detection of HIV-1 CD41 T lymphocytes, E. coli and S. aureus in
various matrices including whole blood, plasma, and peritoneal dialysis fluid. We also reported various cellulose paper and flexible
substrate-based platforms allowing broadly applicable diagnostic
assays through seamlessly integrating optical and electrical sensing
modalities. Thus, these various platforms are uniquely able to isolate
7
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Figure 5 | A flexible material (i.e., polyester film)-based platform for the capture of CD41 T lymphocytes for HIV-1 diagnosis. In the experiments, glass
was determined as a standard substrate, and compared with polyester film (3915 300ga HostaphanH). (A) Intensity plots for glass and HostaphanH.
Images are taken using various fluorescent filters (DAPI, GFP, and CY5) and exposure time. (B) Fluorescent intensity produced by surface immobilized
NeutrAvidin conjugated FITC at various concentrations. (C) Fluorescent images of captured cells on these flexible film-based microfluidic devices. (i)
Bright-field image, (ii) DAPI image staining nucleated cells, and (iii) Alexa647 stained CD41 T lymphocytes cells. (D) Comparison of CD41 T
lymphocytes capture efficiency from whole blood using the platform at various anti-CD4 capture antibody concentrations. There was no statistical
difference observed between the groups (n 5 3, p . 0.05). (E) Comparison of capture specificity from whole blood using the platform at various anti-CD4
capture antibody concentrations. There was no statistical difference observed between the groups (n 5 3, p . 0.05). Statistical assessment was performed
using ANOVA with Tukey’s posthoc test for multiple comparisons. Statistical significance threshold was set at 0.05 (p , 0.05). Error bars represent
standard deviation of the mean.

and detect multiple biotargets selectively, sensitively, and repeatably
from diverse biological matrices using antibodies and peptides.
Further, these platforms could potentially be adapted and tailored
to detect other pathogens and biotargets with well-known biomarkers13,34,37–42.
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